Lifeworks Advisors LLC Has $1.01 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Lifeworks Advisors LLC raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 378.2% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,037 shares of the medical equipment provider's stock after buying an additional 1,611 shares during the quarter. Lifeworks Advisors LLC's holdings in Intuitive Surgical were worth $1,009,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in the company. Norges Bank acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $2,401,493,000. GAMMA Investing LLC increased its position in Intuitive Surgical by 54,010.7% in the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after acquiring an additional 3,022,979 shares during the period. Capital Research Global Investors boosted its stake in Intuitive Surgical by 25.5% during the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock valued at $1,764,904,000 after purchasing an additional 687,906 shares in the last quarter. Northern Trust Corp boosted its stake in Intuitive Surgical by 15.8% during the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after purchasing an additional 494,496 shares in the last quarter. Finally, Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Intuitive Surgical during the 4th quarter valued at $167,943,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on ISRG shares. Citigroup reaffirmed a "buy" rating and set a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Wells Fargo & Company upped their price target on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a research note on Wednesday. Erste Group Bank reissued a "hold" rating on shares of Intuitive Surgical in a report on Wednesday. Robert W. Baird dropped their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. Finally, Evercore ISI boosted their price target on Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research note on Tuesday, July 8th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $592.05.

Intuitive Surgical Stock Up 1.5%

NASDAQ:ISRG traded up $7.25 during trading hours on Friday, hitting $495.86. 1,870,941 shares of the stock were exchanged, compared to its average volume of 1,842,693. The company's 50 day moving average is $529.86 and its two-hundred day moving average is $535.13. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a market capitalization of $177.76 billion, a P/E ratio of 69.16, a price-to-earnings-growth ratio of 5.45 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business's revenue for the quarter was up 21.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.78 EPS. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at $173,845.44. This represents a 92.73% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the sale, the director owned 6,371 shares of the company's stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 7,798 shares of company stock worth $3,955,331. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.